Young-Chul Park
Chief Executive Officer at MOA LIFE PLUS CO. LTD.
Net worth: 14 M $ as of 2024-03-30
Profile
Young-Chul Park is currently the CEO, Director & Head-Management at BL Pharmtech Corp.
and the Chief Executive Officer & Director at BL Corp.
(South Korea).
Previously, he held the position of Chief Executive Officer & Director at TCM Biosciences, Inc. Dr. Park holds a doctorate degree from Yonsei University and an undergraduate degree from Kyung Hee University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MOA LIFE PLUS CO. LTD.
22.45% | 2024-04-15 | 7,244,268 ( 22.45% ) | 14 M $ | 2024-03-30 |
BL PHARMTECH CORP.
0.18% | 2024-03-17 | 161,742 ( 0.18% ) | 58 149 $ | 2024-03-30 |
Young-Chul Park active positions
| Companies | Position | Start |
|---|---|---|
| MOA LIFE PLUS CO. LTD. | Chief Executive Officer | - |
| BL PHARMTECH CORP. | Director/Board Member | - |
Former positions of Young-Chul Park
| Companies | Position | End |
|---|---|---|
TCM Biosciences, Inc.
 TCM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology TCM Biosciences, Inc. engages in the provision of electrical diagnostic services. Its products include human papillomavirus self collection kit, sample preparation equipment, respiratory disease diagnosis, glizigen, cosmeceuticals, and medical devices. The company was founded on August 3, 2009 and is headquartered in Seongnam-si, South Korea. | Chief Executive Officer | - |
Training of Young-Chul Park
| Yonsei University | Doctorate Degree |
| Kyung Hee University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MOA LIFE PLUS CO. LTD. | Health Technology |
| Private companies | 2 |
|---|---|
| BL Pharmtech Corp. | |
TCM Biosciences, Inc.
TCM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology TCM Biosciences, Inc. engages in the provision of electrical diagnostic services. Its products include human papillomavirus self collection kit, sample preparation equipment, respiratory disease diagnosis, glizigen, cosmeceuticals, and medical devices. The company was founded on August 3, 2009 and is headquartered in Seongnam-si, South Korea. | Health Technology |
- Stock Market
- Insiders
- Young-Chul Park
